<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-2AP4K3WP</identifier><date>2010</date><creator>Ocvirk, Janja</creator><relation>documents/doc/2/URN_NBN_SI_doc-2AP4K3WP_001.pdf</relation><relation>documents/doc/2/URN_NBN_SI_doc-2AP4K3WP_001.txt</relation><format format_type="issue">1</format><format format_type="volume">14</format><format format_type="type">article</format><format format_type="extent">str. 34-36</format><identifier identifier_type="ISSN">1408-1741</identifier><identifier identifier_type="COBISSID">968571</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-2AP4K3WP</identifier><language>slv</language><publisher>Onkološki inštitut Ljubljana</publisher><source>Onkologija (Ljubljana)</source><rights>BY</rights><subject language_type_id="eng">Antibodies, monoclonal</subject><subject language_type_id="eng">Carcinoma</subject><subject language_type_id="eng">Chemotherapy, adjuvant</subject><subject language_type_id="eng">Drug therapy</subject><subject language_type_id="slv">karcinom</subject><subject language_type_id="eng">Radiotherapy, adjuvant</subject><subject language_type_id="eng">Stomach neoplasms</subject><subject language_type_id="eng">Survival, analysis</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">zdravljenje</subject><subject language_type_id="slv">želodec</subject><title>Novosti v sistemskem zdravljenju karcinoma želodca</title></Record>